Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Shares of Eton Pharmaceuticals Inc (NASDAQ:ETON) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued FY26 revenue guidance above estimates.

Eton Pharmaceuticals reported quarterly earnings of 43 cents per share which beat the analyst consensus estimate of 10 cents per share. The company reported quarterly sales of $37.568 million which beat the analyst consensus estimate of $27.119 million.

Eton Pharmaceuticals shares jumped 22.1% to $49.80 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Akanda Corp (NASDAQ:AKAN) gained 88.6% to $9.45 in pre-market trading after the company announced its subsidiary, First Towers & Fiber, provided an update on its operational milestones and expansion progress.
• Capricor Therapeutics Inc (NASDAQ:CAPR) rose 68.1% to $7.08 in pre-market trading after the company announced second-quarter results for the period ended Jun. 30.
• China SXT Pharmaceuticals Inc (NASDAQ:SXTC) rose 57.2% to $5.19 in pre-market trading. China SXT Pharmaceuticals recently announced a 1-for-80 reverse stock split.
• Digital Asset Acquisition Corp (NASDAQ:DAAQ) rose 41.1% to $10.24 in pre-market trading after disclosing it mutually terminated its business combination agreement with Old Glory Holding Company, a Delaware-based bank holding company.
• Boxlight Corp (NASDAQ:BOXL) gained 46.5% to $9.96 in pre-market trading after dipping 14% on Thursday. Boxlight recently announced a financing package and second-quarter results
• Onfolio Holdings Inc (NASDAQ:ONFO) rose 30.7% to $3.02 in pre-market trading. On Aug. 11, Onfolio filed a Securities and Exchange Commission filing disclosing results from its Aug. 6 Annual Meeting.
• International Money Express Inc (NASDAQ:IMXI) rose 28.2% to $15.00 in pre-market trading. Western Union and Intermex announced that the parties have received regulatory approval from the New York State Department of Financial Services for Western Union’s pending acquisition of Intermex.
• Heartflow Inc (NASDAQ:HTFL) shares gained 24.7% to $38.68 in pre-market trading after the company reported better-than-expected second-quarter adjusted EPS results.
• Valneva SE (NASDAQ:VALN) rose 16.8% to $6.60 in pre-market trading. Pfizer Inc. (NYSE:PFE) and Valneva disclosed that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies’ Lyme disease vaccine candidate.

Losers

• Innventure Inc (NASDAQ:INV) tumbled 43.1% to $2.05 in pre-market trading after the company reported mixed second-quarter financial results.
• Blaize Holdings Inc (NASDAQ:BZAI) fell 32.9% to $0.78 in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY26 sales guidance below estimates.
• Amplitech Group Inc (NASDAQ:AMPG) declined 26.1% to $4.43 in pre-market trading after the company reported mixed second-quarter financial results.
• SoundThinking Inc (NASDAQ:SSTI) fell 24.3% to $6.26 in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY26 sales guidance below estimates.
• Veritone Inc (NASDAQ:VERI) fell 22.8% to $1.15 in pre-market trading after the company reported mixed second-quarter financial results and cut its FY26 sales guidance below estimates.
• XChange TEC.INC (NASDAQ:XHG) fell 20.5% to $3.26 in pre-market trading after gaining 348% on Thursday. The company announced signing of a non-binding letter of intent to acquire First Cycle.
• TSS Inc (NASDAQ:TSSI) fell 20.2% to $9.55 in pre-market trading after the company reported worse-than-expected quarterly financial results.
• Beyondspring Inc (NASDAQ:BYSI) fell 18.4% to $0.81 in pre-market trading. BeyondSpring shares jumped 34% on Thursday after its subsidiary SEED Therapeutics secured FDA Orphan Drug Designation for Neuroblastoma candidate ST‑01156.
• ARS Pharmaceuticals Inc (NASDAQ:SPRY) fell 15.4% to $5.16 in pre-market trading after the company reported mixed quarterly financial results.
• York Space Systems Inc (NYSE:YSS) fell 15% to $9.78 in pre-market trading after the company reported mixed second-quarter financial results and cut its FY26 sales guidance below estimates.

Photo via Shutterstock